(JBOG) Jacques Bogart - Ratings and Ratios
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0012872141
Fragrances, Cosmetics, Fashion
Description: JBOG Jacques Bogart
from yearly Income Tax Expense
JBOG Stock Overview
Market Cap in USD | 69m |
Sub-Industry | Personal Care Products |
IPO / Inception |
JBOG Stock Ratings
Growth Rating | -71.1% |
Fundamental | 76.5% |
Dividend Rating | 16.0% |
Return 12m vs S&P 500 | -48.4% |
Analyst Rating | - |
JBOG Dividends
Dividend Yield 12m | 3.42% |
Yield on Cost 5y | 2.29% |
Annual Growth 5y | -2.76% |
Payout Consistency | 78.9% |
Payout Ratio | 50.4% |
JBOG Growth Ratios
Growth Correlation 3m | -93.8% |
Growth Correlation 12m | -97.4% |
Growth Correlation 5y | -81% |
CAGR 5y | -10.82% |
CAGR/Max DD 5y | -0.16 |
Sharpe Ratio 12m | -0.11 |
Alpha | -50.50 |
Beta | 0.281 |
Volatility | 25.80% |
Current Volume | 1.3k |
Average Volume 20d | 0.4k |
Stop Loss | 3.8 (-4%) |
Signal | -0.59 |
Piotroski VR‑10 (Strict, 0-10) 6.5
Net Income (3.33m TTM) > 0 and > 6% of Revenue (6% = 35.3m TTM) |
FCFTA 0.10 (>2.0%) and ΔFCFTA 6.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 6.61% (prev 13.99%; Δ -7.38pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.12 (>3.0%) and CFO 48.8m > Net Income 3.33m (YES >=105%, WARN >=100%) |
Net Debt (168.6m) to EBITDA (65.2m) ratio: 2.59 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (14.7m) change vs 12m ago NaN% (target <= -2.0% for YES) |
Gross Margin 26.69% (prev 15.26%; Δ 11.43pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 151.3% (prev 76.99%; Δ 74.26pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 0.87 (EBITDA TTM 65.2m / Interest Expense TTM 13.3m) >= 6 (WARN >= 3) |
Altman Z'' 1.56
(A) 0.10 = (Total Current Assets 194.2m - Total Current Liabilities 155.4m) / Total Assets 398.7m |
(B) 0.16 = Retained Earnings (Balance) 62.7m / Total Assets 398.7m |
(C) 0.03 = EBIT TTM 11.6m / Avg Total Assets 388.5m |
(D) 0.20 = Book Value of Equity 63.9m / Total Liabilities 316.8m |
Total Rating: 1.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.48
1. Piotroski 6.50pt = 1.50 |
2. FCF Yield 31.14% = 5.0 |
3. FCF Margin 6.52% = 1.63 |
4. Debt/Equity 1.31 = 1.70 |
5. Debt/Ebitda 1.64 = 0.71 |
6. ROIC - WACC 5.66% = 7.07 |
7. RoE 4.20% = 0.35 |
8. Rev. Trend 68.06% = 3.40 |
9. Rev. CAGR 16.58% = 2.07 |
10. EPS Trend 21.65% = 0.54 |
11. EPS CAGR 49.93% = 2.50 |
What is the price of JBOG shares?
As of August 31, 2025, the stock is trading at EUR 3.96 with a total of 1,272 shares traded.
Over the past week, the price has changed by -1.00%, over one month by -5.71%, over three months by -21.33% and over the past year by -39.66%.
Over the past week, the price has changed by -1.00%, over one month by -5.71%, over three months by -21.33% and over the past year by -39.66%.
Is Jacques Bogart a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Jacques Bogart (PA:JBOG) is currently (August 2025)
ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 76.48 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JBOG is around 3.21 EUR . This means that JBOG is currently overvalued and has a potential downside of -18.94%.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JBOG is around 3.21 EUR . This means that JBOG is currently overvalued and has a potential downside of -18.94%.
Is JBOG a buy, sell or hold?
Jacques Bogart has no consensus analysts rating.
What are the forecasts/targets for the JBOG price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 10.1 | 155.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 3.5 | -10.9% |
JBOG Fundamental Data Overview
Market Cap USD = 69.4m (59.6m EUR * 1.1648 EUR.USD)
Market Cap EUR = 59.6m (59.6m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 43.2m EUR (Cash And Short Term Investments, last quarter)
P/S = 0.2057
P/B = 0.7189
Beta = 0.608
Revenue TTM = 587.6m EUR
EBIT TTM = 11.6m EUR
EBITDA TTM = 65.2m EUR
Long Term Debt = 54.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 52.3m EUR (from shortTermDebt, last quarter)
Debt = 106.6m EUR (Calculated: Short Term 52.3m + Long Term 54.3m)
Net Debt = 168.6m EUR (from netDebt column, last quarter)
Enterprise Value = 123.0m EUR (59.6m + Debt 106.6m - CCE 43.2m)
Interest Coverage Ratio = 0.87 (Ebit TTM 11.6m / Interest Expense TTM 13.3m)
FCF Yield = 31.14% (FCF TTM 38.3m / Enterprise Value 123.0m)
FCF Margin = 6.52% (FCF TTM 38.3m / Revenue TTM 587.6m)
Net Margin = 0.57% (Net Income TTM 3.33m / Revenue TTM 587.6m)
Gross Margin = 26.69% ((Revenue TTM 587.6m - Cost of Revenue TTM 430.8m) / Revenue TTM)
Tobins Q-Ratio = 1.93 (Enterprise Value 123.0m / Book Value Of Equity 63.9m)
Interest Expense / Debt = 4.43% (Interest Expense 4.72m / Debt 106.6m)
Taxrate = 133.8% (set to none) (from yearly Income Tax Expense: 1.46m / 1.09m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.25 (Total Current Assets 194.2m / Total Current Liabilities 155.4m)
Debt / Equity = 1.31 (Debt 106.6m / last Quarter total Stockholder Equity 81.6m)
Debt / EBITDA = 1.64 (Net Debt 168.6m / EBITDA 65.2m)
Debt / FCF = 2.78 (Debt 106.6m / FCF TTM 38.3m)
Total Stockholder Equity = 79.3m (last 4 quarters mean)
RoA = 0.83% (Net Income 3.33m, Total Assets 398.7m )
RoE = 4.20% (Net Income TTM 3.33m / Total Stockholder Equity 79.3m)
RoCE = 8.66% (Ebit 11.6m / (Equity 79.3m + L.T.Debt 54.3m))
RoIC = 5.66% (Ebit 11.6m / (Assets 398.7m - Current Assets 194.2m))
WACC = unknown (E(59.6m)/V(166.2m) * Re(7.05%)) + (D(106.6m)/V(166.2m) * Rd(4.43%) * (1-Tc(none)))
Shares Correlation 5-Years: -90.0 | Cagr: -0.32%
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈28.4m ; Y1≈18.6m ; Y5≈8.52m
Fair Price DCF = 11.41 (DCF Value 167.4m / Shares Outstanding 14.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 68.06 | Revenue CAGR: 16.58%
Rev Growth-of-Growth: -48.63
EPS Correlation: 21.65 | EPS CAGR: 49.93%
EPS Growth-of-Growth: 215.3
Market Cap EUR = 59.6m (59.6m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 43.2m EUR (Cash And Short Term Investments, last quarter)
P/S = 0.2057
P/B = 0.7189
Beta = 0.608
Revenue TTM = 587.6m EUR
EBIT TTM = 11.6m EUR
EBITDA TTM = 65.2m EUR
Long Term Debt = 54.3m EUR (from longTermDebt, last quarter)
Short Term Debt = 52.3m EUR (from shortTermDebt, last quarter)
Debt = 106.6m EUR (Calculated: Short Term 52.3m + Long Term 54.3m)
Net Debt = 168.6m EUR (from netDebt column, last quarter)
Enterprise Value = 123.0m EUR (59.6m + Debt 106.6m - CCE 43.2m)
Interest Coverage Ratio = 0.87 (Ebit TTM 11.6m / Interest Expense TTM 13.3m)
FCF Yield = 31.14% (FCF TTM 38.3m / Enterprise Value 123.0m)
FCF Margin = 6.52% (FCF TTM 38.3m / Revenue TTM 587.6m)
Net Margin = 0.57% (Net Income TTM 3.33m / Revenue TTM 587.6m)
Gross Margin = 26.69% ((Revenue TTM 587.6m - Cost of Revenue TTM 430.8m) / Revenue TTM)
Tobins Q-Ratio = 1.93 (Enterprise Value 123.0m / Book Value Of Equity 63.9m)
Interest Expense / Debt = 4.43% (Interest Expense 4.72m / Debt 106.6m)
Taxrate = 133.8% (set to none) (from yearly Income Tax Expense: 1.46m / 1.09m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.25 (Total Current Assets 194.2m / Total Current Liabilities 155.4m)
Debt / Equity = 1.31 (Debt 106.6m / last Quarter total Stockholder Equity 81.6m)
Debt / EBITDA = 1.64 (Net Debt 168.6m / EBITDA 65.2m)
Debt / FCF = 2.78 (Debt 106.6m / FCF TTM 38.3m)
Total Stockholder Equity = 79.3m (last 4 quarters mean)
RoA = 0.83% (Net Income 3.33m, Total Assets 398.7m )
RoE = 4.20% (Net Income TTM 3.33m / Total Stockholder Equity 79.3m)
RoCE = 8.66% (Ebit 11.6m / (Equity 79.3m + L.T.Debt 54.3m))
RoIC = 5.66% (Ebit 11.6m / (Assets 398.7m - Current Assets 194.2m))
WACC = unknown (E(59.6m)/V(166.2m) * Re(7.05%)) + (D(106.6m)/V(166.2m) * Rd(4.43%) * (1-Tc(none)))
Shares Correlation 5-Years: -90.0 | Cagr: -0.32%
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈28.4m ; Y1≈18.6m ; Y5≈8.52m
Fair Price DCF = 11.41 (DCF Value 167.4m / Shares Outstanding 14.7m; 5y FCF grow -40.0% → 3.0% )
Revenue Correlation: 68.06 | Revenue CAGR: 16.58%
Rev Growth-of-Growth: -48.63
EPS Correlation: 21.65 | EPS CAGR: 49.93%
EPS Growth-of-Growth: 215.3